Shares of Outlook Therapeutics, Inc. (NASDAQ:OTLK – Get Rating) have been given an average recommendation of “Buy” by the seven brokerages that are covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have updated their coverage on the stock […]
Shares of Outlook Therapeutics, Inc. (NASDAQ:OTLK – Get Rating) have been given an average recommendation of “Buy” by the seven ratings firms that are currently covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12 month price objective among brokers that have issued a report […]
Outlook Therapeutics, Inc. (NASDAQ:OTLK – Get Rating) insider Terry Dagnon sold 520,000 shares of the firm’s stock in a transaction on Thursday, April 20th. The stock was sold at an average price of $1.14, for a total transaction of $592,800.00. Following the transaction, the insider now directly owns 653,058 shares of the company’s stock, valued […]
Outlook Therapeutics® Announces Validation of Marketing Authorization Application by the European Medicines Agency for ONS-5010 as a Treatment for Wet AMD streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Outlook Therapeutics® Announces Acceptance of Biologics License Application by U S FDA for ONS-5010 as a Treatment for Wet AMD forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.